Krüppel-like factors KLF2 and 6 and Ki-67 are direct targets of zoledronic acid in MCF-7 cells
Authors:
- Regina EbertRERegina Ebert
- Sabine ZeckSZSabine Zeck
- Jutta Meissner-WeiglJMJutta Meissner-Weigl
- Barbara KlotzBKBarbara Klotz
- Tilman D. RachnerTRTilman D. Rachner
- Peggy BenadPBPeggy Benad
- Ludger Klein-HitpassLKLudger Klein-Hitpass
- Maximilian RudertMRMaximilian Rudert
- Lorenz C. HofbauerLHLorenz C. Hofbauer
- Franz JakobFJFranz Jakob
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Bisphosphonates as Treatment of Bone MetastasesCurrent Pharmaceutical Design, 2010
- Effect of bisphosphonates on pain and quality of life in patients with bone metastasesNature Reviews Clinical Oncology, 2009
- Osteotropic cancers: From primary tumor to boneCancer Letters, 2009
- Transitions between epithelial and mesenchymal states in development and diseaseSeminars in Cell & Developmental Biology, 2008
- Fatal attraction: why breast cancer cells home to boneBreast Cancer Research, 2008
- Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacyOsteoporosis International, 2008
- BisphosphonatesAnnals of the New York Academy of Sciences, 2007
- Mevalonate pathway: A review of clinical and therapeutical implicationsClinical Biochemistry, 2007
- A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen‐containing bisphosphonatesBritish Journal of Pharmacology, 2006
- Mechanisms of osteolytic bone metastases in breast carcinomaCancer, 2003